Compare ADMA Biologics Inc (ADMA) vs Cardinal Health Inc (CAH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Cardinal Health Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Cardinal Health Inc trades at $240.42 (market cap $55.88B). The key difference: Cardinal Health Inc is far larger — about 25.2× ADMA Biologics Inc's market cap, and Cardinal Health Inc pays a 0.86% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | CAH | |
|---|---|---|
Market Cap | $2.22B | $55.88B |
Sector | Health | Health |
52-Week High | $20.38 | $240.26 |
52-Week Low | $7.60 | $146.04 |
Enterprise Value | $2.29B | $59.91B |
Dividend Yield | — | 0.86% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →
